Biopharmaceuticals



“I Don’t Care If The Market Is Crashing, Rebounding... Or Just Going Sideways…”

Retire In 18 Months With $2.4 Million Regardless Of Market Conditions? It takes a certain sort of person to sit back while the global markets are on fire and say, ‘I just don’t care…bring it on.

Read More
Biopharmaceuticals
Biotech
Health
Stock Picks

4 Promising Stocks At The Top Of Goldman Sachs’ COVID-19 Healthcare List

These 4 names are making big strides in treatments and vaccines for the the coronavirus.

Read More
Airlines
Biopharmaceuticals
Biotech
Crude Oil
Daily Rundown
Donald Trump
Economic Trends
Economy
Federal Reserve
Oil
Stock Picks
US Economy

The Fed Just Announced Another $2.3 Trillion In Financing Programs As Jobless Claims Surge By 6.6 Million

Plus, the Trump Administration is reportedly launching a new coronavirus task force focused on the economic devastation caused by the pandemic, oil rose on reports Saudi Arabia and Russia have come to agreement on a massive production cut, and airline stocks are on the rise after Mnuchin said airlines could hear back on their applications for government aid by as soon as tomorrow.

Read More
Biopharmaceuticals
Consumer Staples
Defensive Stocks
Fibonacci Retracement
Fundamental Analysis
InvestivDaily
Pharmaceuticals
Sector Rotation
Technical Analysis
Value Investing

JNJ is up big-time on COVID-19 vaccine hopes – are they justified?

Years ago, as I began my career as an investor, I read a book by Peter Lynch. Mr. Lynch had made his name, and his fortune, as the manager of Fidelity’s flagship Magellan fund in the late 70’s and ’80’s, and his incredible performance was one of the big reasons Magellan, at the time, was […]

Read More
Biopharmaceuticals
Defensive Stocks
Fibonacci Retracement
Fundamental Analysis
InvestivDaily
Pharmaceuticals
Risk
Sector Rotation
Technical Analysis
Value Investing

MRK is up almost 21% in the last two weeks. Is it a good buy?

As I’ve studied the market over the years, one of the intriguing contrasts comes in the way different analysis methods take in the “big picture” of the market. That includes the way that fundamental investors and analysts look at the market versus those that prefer to work on strictly technical terms. I like to work […]

Read More
Apple
Banking Sector
Biomedical
Biopharmaceuticals
Biotech
Crude Oil
Daily Rundown
Investment Banks
Oil
Recession
Stock Picks

Stocks Are Higher Even As U.S. Surgeon General Says This Week “Is Going To Be Our 9/11” Moment Amid The COVID-19 Pandemic

Plus, JPMorgan’s Jaime Dimon said the coronavirus crisis will produce a “bad recession,” oil is lower as the OPEC+ meeting to discuss a production cut is delayed, and Apple said it will deliver 1 million face shields per week starting this week.

Read More
Bear Market
Biomedical
Biopharmaceuticals
Biotech
Crude Oil
Daily Rundown
Donald Trump
Oil
Pharmaceuticals
Retailers
Software
Stock Picks
Volatility
Volatility Index

Oil Just Fell To An 18-Year Low & Could Keep Falling – Here’s Why

Plus, President Trump abandoned his hope of re-opening the U.S. economy by Easter as cases surge to more than 143,000, Macy’s said it is furloughing the majority of its 130,000 employees, and Johnson & Johnson said it will begin human trails on its experimental COVID-19 vaccine by September.

Read More
Bear Market
Biomedical
Biopharmaceuticals
Biotech
Daily Rundown
Donald Trump
Economic Trends
Economy
Pharmaceuticals
Recession
Stock Market Crash
Stock Picks
US Economy

Consumer Sentiment Slipped By The Most Since October 2008 This Month As The Coronavirus Grinds The U.S. Economy To A Halt

Plus, the $2 trillion stimulus bill has hit a snag in the House, the U.S. now has the most cases of the coronavirus in the world, and Novartis’ CEO said it’s “too soon” to say if two anti-malaria drugs will be an effective vaccine against the deadly virus.

Read More
Auto Industry
Bear Market
Biomedical
Biopharmaceuticals
Biotech
Crude Oil
Daily Rundown
Dividends
Economic Trends
Economy
Oil
Recession
Shale Oil
Stock Picks
US Economy

Chevron Shares Rocket Higher After The Company Said It Will Maintain Its Dividend

Plus, the market is higher on optimism that a third stimulus bill will be finalized today, Gilead Sciences’ experimental COVID-19 treatment, remdesivir, received Orphan Drug Designation from the FDA, and General Motors said it is conserving cash and drawing down $16 billion from credit lines.

Read More

FREE TRAINING - TRADERSPRO PRESENTS: Retire In 18 Months With $2.4 Million?

Join Us Now
X